ArticleCancer chemotherapy and pharmacology2017

Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer.

Hideki Ohta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.